New Enterprise Associates

News, insights, analysis and data

← Back to New Enterprise Associates profile

New Enterprise Associates related stories

All articles and analysis

  • GraphLab changes name to Dato, picks up $18.5 mln Series B
    Iris Dorbian- 8 January 2015

    GraphLab has secured $18.5 million in Series B funding. Vulcan Capital led the round with participation from Opus Capital and return backers New Enterprise Associates and Madrona Venture Group. Also, GraphLab has changed its name to Dato. Based in Seattle, Dato is a platform for building predictive and intelligent applications.

  • Blend Therapeutics scores $21 mln
    Iris Dorbian- 7 January 2015

    Watertown, Mass.-based Blend Therapeutics, a biopharmaceutical firm focused on treating cancer, has raised $21 million in funding. Blend's investors include New Enterprise Associates, Flagship Ventures, NanoDimension and Eminent Venture Capital.

  • Fund briefs recap
    VCJ Staff- 1 January 2015

    A summary of fundraising news worldwide, including Artis, Obvious, Fenox, IQ Capital, Golden and others

  • 3-V Biosciences snags $28.5 mln Series D
    Iris Dorbian- 31 December 2014

    Menlo Park, Calif.-based biopharmaceutical firm 3-V Biosciences has closed $28.5 million in Series D funding. New Enterprise Associates, Kleiner Perkins Caufield & Byers and Rock Springs Capital Management led the round with participation from other investors that included Ally Bridge Group.

  • Interleukin Genetics snags $10 mln
    Iris Dorbian- 24 December 2014

    Interleukin Genetics has closed a $5 million private placement. The investors included New Enterprise Associates and Bay City Capital. According to terms of the agreement, Interleukin has agreed to sell over 50 million shares of its common stock at $0.1003 per share. BTIG was the placement agent for the transaction. Also, Horizon Technology Finance Corp. has agreed to provide a $5 million loan to Interleukin. Headquartered in Waltham, Mass., Interleukin Genetics is a maker of proprietary genetic tests for chronic diseases and health related conditions.

  • Top ten VC deals done in Canada in 2014
    brad meikle- 23 December 2014

    The Canadian Venture Capital & Private Equity Association (CVCA) and research partner Thomson Reuters will in February 2015 publish their full report on Canadian venture capital market activity in 2014. In the meantime, peHUB Canada has compiled a list of the likely top 10 (disclosed) financings completed this year.

  • Venture fundraising hits post-bubble high
    VCJ Staff- 18 December 2014

    A surge of late year fundraising drove the venture industry to another post dot-com bubble record: about $33 billion was raised by U.S.-based VCs for new funds in 2014, the most since 2001.

  • Data company Mattermark raises $6.5 mln, Feld joins board
    Alastair Goldfisher- 16 December 2014

    Mattermark, which provides a data platform used by investors to track private companies, has raised a $6.5 million Series A round that was led by Foundry Group. The San Francisco-based company was founded in 2013 and has now raised $11.3 million in total funding. Participating in the Series A was many of the company's seed-stage investors, including 500 Startups, Andreessen Horowitz, Data Collective, Sherpa Ventures, Felicis Ventures, New Enterprise Associates, Version One Ventures and many individuals, including Jeff Lawson, Carter Rabasa, Damien Tanner, Daniel Clark, Eileen Burbidge, Elliot Loh, Enrico Pandian, Eric Ries, Ullas Naik and others. As part of the Series A round, Brad Feld, managing director of Foundry, has joined the Mattermark board.

  • Mike Cahill rejoins VC-backed Boku as CTO
    Iris Dorbian- 11 December 2014

    Boku has hired Mike Cahill as chief technology officer. Previously, Cahill worked at American Express where he was vice president of mobile engineering. And, prior to that, Cahill was Boku's vice president of engineering. Based in San Francisco, Boku is a carrier billing-based mobile payment company. It is backed by Andreessen Horowitz, Benchmark Capital, DAG Ventures, Index Ventures, Khosla Ventures and New Enterprise Associates.

  • Madrona unveils in-house incubator for idea-stage companies
    Mark Boslet- 10 December 2014

    Venture capitalists say they like to become involved with companies early. How about before they start! That is the motivation behind Madrona Venture Labs, an incubator for idea-stage companies sponsored and funded by Madrona Venture Group.